Clinical Trials Directory

Trials / Unknown

UnknownNCT04103008

Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography

Effect of Residual Myocardial Ischemia on Recovery of Left Ventricular Function After Primary Percutaneous Coronary Intervention

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Recovery of the left ventricular function is variable from one patient to another, thus assessment of cardiac function by measuring left ventricular ejection fraction using echocardiography is the most common in the daily clinical practice. However, this technique has limitation related with its intra- and interobserver variability. A recent technique, 2D speckle tracking for assessing global longitudinal strain, has been introduced to reduce the variability and potentially has a higher accuracy. Speckle tracking is a method which uses two dimensions recording for measuring quantity of movement of myocardium in several segments. Speckle-tracking echocardiography is a current noninvasive ultrasound imaging technique that allows for an objective and quantitative evaluation of global and regional myocardial function independently from the angle of insonation and from cardiac translational movements,

Detailed description

Authors using 2D speckle tracking found that subclinical LV systolic dysfunction is common in patients with isolated severe mitral stenosis (MS) and is determined primarily by the hemodynamic variables of MS severity and reduced LV filling. BMV results in rapid recovery of LV systolic function in these patients through improvement in LV diastolic loading. These findings suggest that LV contractile properties in MS are modulated predominantly by LV diastolic filling rather than myocardial structural abnormality.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSpeckle tracking echocardiographyassess left ventricular function on admission and after 40 days

Timeline

Start date
2019-11-01
Primary completion
2020-09-01
Completion
2020-12-01
First posted
2019-09-25
Last updated
2019-09-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04103008. Inclusion in this directory is not an endorsement.